BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24558447)

  • 1. Identification and characterization of sebaceous gland atrophy-sparing DGAT1 inhibitors.
    Muise ES; Zhu Y; Verras A; Karanam BV; Gorski J; Weingarth D; Lin HV; Hwa J; Thompson JR; Hu G; Liu J; He S; DeVita RJ; Shen DM; Pinto S
    PLoS One; 2014; 9(2):e88908. PubMed ID: 24558447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological inhibition of DGAT1 induces sebaceous gland atrophy in mouse and dog skin while overt alopecia is restricted to the mouse.
    Floettmann E; Lees D; Seeliger F; Jones HB
    Toxicol Pathol; 2015 Apr; 43(3):376-83. PubMed ID: 25112279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of the research and development of diacylglycerol O-acyltransferase 1 (DGAT1) inhibitors.
    DeVita RJ; Pinto S
    J Med Chem; 2013 Dec; 56(24):9820-5. PubMed ID: 23919406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Class of Diacylglycerol Acyltransferase 1 Inhibitors Identified by a Combination of Phenotypic High-throughput Screening, Genomics, and Genetics.
    Tschapalda K; Zhang YQ; Liu L; Golovnina K; Schlemper T; Eichmann TO; Lal-Nag M; Sreenivasan U; McLenithan J; Ziegler S; Sztalryd C; Lass A; Auld D; Oliver B; Waldmann H; Li Z; Shen M; Boxer MB; Beller M
    EBioMedicine; 2016 Jun; 8():49-59. PubMed ID: 27428418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel quinoline carboxylic acid series as DGAT1 inhibitors.
    Zhou G; Ting PC; Wishart G; Zorn N; Aslanian RG; Lin M; Smith M; Walker SS; Cook J; Van Heek M; Lachowicz J
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1790-4. PubMed ID: 24618302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin modulates the effects of acyl CoA:diacylglycerol acyltransferase deficiency on murine fur and sebaceous glands.
    Chen HC; Smith SJ; Tow B; Elias PM; Farese RV
    J Clin Invest; 2002 Jan; 109(2):175-81. PubMed ID: 11805129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) with small molecule inhibitors for the treatment of metabolic diseases.
    Cao J; Zhou Y; Peng H; Huang X; Stahler S; Suri V; Qadri A; Gareski T; Jones J; Hahm S; Perreault M; McKew J; Shi M; Xu X; Tobin JF; Gimeno RE
    J Biol Chem; 2011 Dec; 286(48):41838-41851. PubMed ID: 21990351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestine-targeted DGAT1 inhibition improves obesity and insulin resistance without skin aberrations in mice.
    Tsuda N; Kumadaki S; Higashi C; Ozawa M; Shinozaki M; Kato Y; Hoshida K; Kikuchi S; Nakano Y; Ogawa Y; Furusako S
    PLoS One; 2014; 9(11):e112027. PubMed ID: 25405858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of thiazole containing biaryl analogs as diacylglycerol acyltransferase 1 (DGAT1) inhibitors.
    Kadam KS; Jadhav RD; Kandre S; Guha T; Reddy MM; Brahma MK; Deshmukh NJ; Dixit A; Doshi L; Srinivasan S; Devle J; Damre A; Nemmani KV; Gupte A; Sharma R
    Eur J Med Chem; 2013 Jul; 65():337-47. PubMed ID: 23735282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological inhibition of stearoyl CoA desaturase in the skin induces atrophy of the sebaceous glands.
    Meingassner JG; Aschauer H; Winiski AP; Dales N; Yowe D; Winther MD; Zhang Z; Stütz A; Billich A
    J Invest Dermatol; 2013 Aug; 133(8):2091-4. PubMed ID: 23446987
    [No Abstract]   [Full Text] [Related]  

  • 11. Accelerating the discovery of DGAT1 inhibitors through the application of parallel medicinal chemistry (PMC).
    Yu Y; Wu Z; Shi ZC; He S; Lai Z; Cernak TA; Vachal P; Liu M; Liu J; Hong Q; Jian T; Guiadeen D; Krikorian A; Sperbeck DM; Verras A; Sonatore LM; Murphy BA; Wiltsie J; Chung CC; Gorski JN; Liu J; Xiao J; Wolff M; Tong SX; Madeira M; Karanam BV; Shen DM; Balkovec JM; De Vita RJ; Pinto S; Nargund RP
    Bioorg Med Chem Lett; 2019 Jun; 29(11):1380-1385. PubMed ID: 30952592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling the mechanism of action of a DGAT1 inhibitor using a causal reasoning platform.
    Enayetallah AE; Ziemek D; Leininger MT; Randhawa R; Yang J; Manion TB; Mather DE; Zavadoski WJ; Kuhn M; Treadway JL; des Etages SA; Gibbs EM; Greene N; Steppan CM
    PLoS One; 2011; 6(11):e27009. PubMed ID: 22073239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of dimethyl pent-4-ynoic acid derivatives, as potent and orally bioavailable DGAT1 inhibitors that suppress body weight in diet-induced mouse obesity model.
    Yu T; Wu C; Shih N; Li Q; Chan C; Pan H; Yao D; Pan Y; Liang W; Shen L; Zhao H; Li J; Chen S
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1686-1692. PubMed ID: 29699923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzimidazole-based DGAT1 inhibitors with a [3.1.0] bicyclohexane carboxylic acid moiety.
    He S; Lai Z; Hong Q; Shang J; Reibarkh M; Kuethe JT; Liu J; Guiadeen D; Krikorian AD; Cernak TA; Dykstra KD; Sperbeck DM; Wu Z; Yu Y; Yang GX; Jian T; Verras A; Sonatore LM; Wiltsie J; Chung CC; Murphy BA; Gorski JN; Liu J; Xiao J; Wolff M; Tong SX; Madeira M; Karanam BV; Shen DM; Balkovec JM; Pinto S; Nargund RP; DeVita RJ
    Bioorg Med Chem Lett; 2019 May; 29(10):1182-1186. PubMed ID: 30926247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of 2-aminooxazole amides as acyl-CoA: diacylglycerol acyltransferase 1 (DGAT1) inhibitors through scaffold hopping strategy.
    Kim HM; Smith MD; Kim JH; Caplen MA; Chan TY; McKittrick BA; Cook JA; van Heek M; Lachowicz J
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6410-4. PubMed ID: 24120540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of pyrrolopyridazines as novel DGAT1 inhibitors.
    Fox BM; Iio K; Li K; Choi R; Inaba T; Jackson S; Sagawa S; Shan B; Tanaka M; Yoshida A; Kayser F
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6030-3. PubMed ID: 20833038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of diamide compounds as diacylglycerol acyltransferase 1 (DGAT1) inhibitors.
    Nakajima K; April M; Brewer JT; Daniels T; Forster CJ; Gilmore TA; Jain M; Kanter A; Kwak Y; Li J; McQuire L; Serrano-Wu MH; Streeper R; Szklennik P; Thompson J; Wang B
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1245-8. PubMed ID: 26804232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 6-phenylpyrimido[4,5-b][1,4]oxazines as potent and selective acyl CoA:diacylglycerol acyltransferase 1 (DGAT1) inhibitors with in vivo efficacy in rodents.
    Fox BM; Sugimoto K; Iio K; Yoshida A; Zhang JK; Li K; Hao X; Labelle M; Smith ML; Rubenstein SM; Ye G; McMinn D; Jackson S; Choi R; Shan B; Ma J; Miao S; Matsui T; Ogawa N; Suzuki M; Kobayashi A; Ozeki H; Okuma C; Ishii Y; Tomimoto D; Furakawa N; Tanaka M; Matsushita M; Takahashi M; Inaba T; Sagawa S; Kayser F
    J Med Chem; 2014 Apr; 57(8):3464-83. PubMed ID: 24670009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiadiazoles as new inhibitors of diacylglycerol acyltransferase type 1.
    Mougenot P; Namane C; Fett E; Camy F; Dadji-Faïhun R; Langot G; Monseau C; Onofri B; Pacquet F; Pascal C; Crespin O; Ben-Hassine M; Ragot JL; Van-Pham T; Philippo C; Chatelain-Egger F; Péron P; Le Bail JC; Guillot E; Chamiot-Clerc P; Chabanaud MA; Pruniaux MP; Schmidt F; Venier O; Nicolaï E; Viviani F
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2497-502. PubMed ID: 22405833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of cyclohexane carboxylic acid head group containing isoxazole and thiazole analogs as DGAT1 inhibitors.
    Kandre S; Bhagat PR; Reddy MM; Dalal R; Dixit A; Deshmukh NJ; Anthony J; Bose J; Anupindi R; Sharma R; Gupte A
    Eur J Med Chem; 2014 May; 79():203-15. PubMed ID: 24735646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.